In the last trading session, 1.11 million Merus N.V (NASDAQ:MRUS) shares changed hands as the company’s beta touched 1.03. With the company’s per share price at $56.45 changed hands at $1.54 or 2.80% during last session, the market valuation stood at $4.20B. MRUS’s last price was a discount, traded about -11.57% off its 52-week high of $62.98. The share price had its 52-week low at $33.19, which suggests the last value was 41.2% up since then.
Analysts gave the Merus N.V (MRUS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MRUS as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Merus N.V’s EPS for the current quarter is expected to be -1.15.
Merus N.V (NASDAQ:MRUS) trade information
Instantly MRUS was in green as seen at the end of in last trading. With action -9.56%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 34.24%, with the 5-day performance at -9.56% in the red. However, in the 30-day time frame, Merus N.V (NASDAQ:MRUS) is 38.02% up.
The consensus price target for the stock as assigned by Wall Street analysts is 110, meaning bulls need an upside of 48.68% from its current market value. According to analyst projections, MRUS’s forecast low is 110 with 110 as the target high. To hit the forecast high, the stock’s price needs a -94.86% plunge from its current level, while the stock would need to soar -94.86% for it to hit the projected low.
Merus N.V (MRUS) estimates and forecasts
Year-over-year growth is forecast to reach 54.23% up from the last financial year.
Consensus estimates given by 15 financial analysts project the company’s revenue in the current quarter to hit an average of 9.88M. 15 analysts are of the opinion that Merus N.V’s revenue for the current quarter will be 9.83M. The company’s revenue for the corresponding quarters a year ago was 7.33M and 11.77M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 34.77%. The estimates for the next quarter sales put growth at -16.51%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.04%. The 2025 estimates are for Merus N.V earnings to decrease by -44.19%, but the outlook for the next 5-year period is at -1.28% per year.
Merus N.V (NASDAQ:MRUS)’s Major holders
RTW INVESTMENTS, LP holds the second largest percentage of outstanding shares, with 6.741% or 4.17 million shares worth $246.7 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and Fidelity Select Portfolios-Health Care Portfolio. With 2.08 shares estimated at $117.48 million under it, the former controlled 3.01% of total outstanding shares. On the other hand, Fidelity Select Portfolios-Health Care Portfolio held about 1.72% of the shares, roughly 1.19 shares worth around $67.19 million.
